This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fichera, M. E.
Right arrow Articles by Roos, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fichera, M. E.
Right arrow Articles by Roos, D. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Jul 1995, 1530-1537, Vol 39, No. 7
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii

ME Fichera, MK Bhopale and DS Roos
Department of Biology, University of Pennsylvania, Philadelphia 19104- 6018, USA.

In order to characterize the delayed effect of clindamycin and macrolide antibiotics against Toxoplasma gondii tachyzoites (E. R. Pfefferkorn and S. E. Borotz, Antimicrob. Agents Chemother. 38:31-37, 1994), we have carefully examined the replication of parasites as a function of time after drug addition. Intracellular tachyzoites treated with up to 20 microM clindamycin (> 1,000 times the 50% inhibitory concentration) exhibit doubling times indistinguishable from those of controls (approximately 7 h). Drug-treated parasites emerge from infected cells and establish parasitophorous vacuoles inside new host cells as efficiently as untreated controls, but replication within the second vacuole is dramatically slowed. Growth inhibition in the second vacuole does not require continued presence of drug, but it is dependent solely on the concentration and duration of drug treatment in the first (previous) vacuole. The susceptibility of intracellular parasites to nanomolar concentrations of clindamycin contrasts with that of extracellular tachyzoites, which are completely resistant to treatment, even through several cycles of subsequent intracellular replication. This peculiar phenotype, in which drug effects are observed only in the second infectious cycle, also characterizes azithromycin and chloramphenicol treatment, but not treatment with cycloheximide, tetracycline, or anisomycin. These findings provide new insights into the mode of clindamycin and macrolide action against T. gondii, although the relevant target for their action remains unknown.


This article has been cited by other articles:

  • Nishi, M., Hu, K., Murray, J. M., Roos, D. S. (2008). Organellar dynamics during the cell cycle of Toxoplasma gondii. J. Cell Sci. 121: 1559-1568 [Abstract] [Full Text]  
  • Dahl, E. L., Rosenthal, P. J. (2007). Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum Apicoplast. Antimicrob. Agents Chemother. 51: 3485-3490 [Abstract] [Full Text]  
  • Sidhu, A. B. S., Sun, Q., Nkrumah, L. J., Dunne, M. W., Sacchettini, J. C., Fidock, D. A. (2007). In Vitro Efficacy, Resistance Selection, and Structural Modeling Studies Implicate the Malarial Parasite Apicoplast as the Target of Azithromycin. J. Biol. Chem. 282: 2494-2504 [Abstract] [Full Text]  
  • Mattana, A., Biancu, G., Alberti, L., Accardo, A., Delogu, G., Fiori, P. L., Cappuccinelli, P. (2004). In Vitro Evaluation of the Effectiveness of the Macrolide Rokitamycin and Chlorpromazine against Acanthamoeba castellanii. Antimicrob. Agents Chemother. 48: 4520-4527 [Abstract] [Full Text]  
  • Dzierszinski, F., Nishi, M., Ouko, L., Roos, D. S. (2004). Dynamics of Toxoplasma gondii Differentiation. Eukaryot Cell 3: 992-1003 [Abstract] [Full Text]  
  • Waller, R. F., Ralph, S. A., Reed, M. B., Su, V., Douglas, J. D., Minnikin, D. E., Cowman, A. F., Besra, G. S., McFadden, G. I. (2003). A Type II Pathway for Fatty Acid Biosynthesis Presents Drug Targets in Plasmodium falciparum. Antimicrob. Agents Chemother. 47: 297-301 [Abstract] [Full Text]  
  • Gubbels, M.-J., Li, C., Striepen, B. (2003). High-Throughput Growth Assay for Toxoplasma gondii Using Yellow Fluorescent Protein. Antimicrob. Agents Chemother. 47: 309-316 [Abstract] [Full Text]  
  • Jelenska, J., Crawford, M. J., Harb, O. S., Zuther, E., Haselkorn, R., Roos, D. S., Gornicki, P. (2001). Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 10.1073/pnas.051629998v1 [Abstract] [Full Text]  
  • Striepen, B., Crawford, M. J., Shaw, M. K., Tilney, L. G., Seeber, F., Roos, D. S. (2000). The Plastid of Toxoplasma gondii Is Divided by Association with the Centrosomes. JCB 151: 1423-1434 [Abstract] [Full Text]  
  • Nakaar, V., Samuel, B. U., Ngo, E. O., Joiner, K. A. (1999). Targeted Reduction of Nucleoside Triphosphate Hydrolase by Antisense RNA Inhibits Toxoplasma gondii Proliferation. J. Biol. Chem. 274: 5083-5087 [Abstract] [Full Text]  
  • Jerome, M. E., Radke, J. R., Bohne, W., Roos, D. S., White, M. W. (1998). Toxoplasma Gondii Bradyzoites Form Spontaneously during Sporozoite-Initiated Development. Infect. Immun. 66: 4838-4844 [Abstract] [Full Text]  
  • Jelenska, J., Crawford, M. J., Harb, O. S., Zuther, E., Haselkorn, R., Roos, D. S., Gornicki, P. (2001). Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 98: 2723-2728 [Abstract] [Full Text]  
  • Hu, K., Mann, T., Striepen, B., Beckers, C. J. M., Roos, D. S., Murray, J. M. (2002). Daughter Cell Assembly in the Protozoan Parasite Toxoplasma gondii. Mol. Biol. Cell 13: 593-606 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»